Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
46 participants
INTERVENTIONAL
2005-01-31
2012-08-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Frequent Hemodialysis Network: Daily Trial
NCT00264758
Comparison of Daily Nocturnal Hemodialysis With Daily Hemodialysis
NCT00012441
Frequent Hemodialysis Network: Nocturnal Trial
NCT00271999
Efficacy of Twice Weekly Hemodialysis in Patients With Residual Kidney Function
NCT03874117
Comparison Study of Daily Ultrafiltration and Twice-weekly Hemodialysis
NCT00825318
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A
Six Day per week short daily hemodialysis
More frequent hemodialysis
Six Day per week short daily hemodialysis
B
Six nights per week nocturnal hemodialysis
More frequent hemodialysis
Six nights per week nocturnal hemodialysis
C
Every other day short daily hemodialysis
More frequent hemodialysis
Every other day short daily hemodialysis
D
Every other night hemodialysis
More frequent hemodialysis
Every other night hemodialysis
E
5 days per week short daily hemodialysis
More frequent hemodialysis
5 days per week short daily hemodialysis
F
5 nights per week hemodialysis
More frequent hemodialysis
5 nights per week hemodialysis
G
Conventional three time per week short daily hemodialysis
Conventional Hemodialysis
3 days per week short daily hemodialysis
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
More frequent hemodialysis
Six Day per week short daily hemodialysis
More frequent hemodialysis
Six nights per week nocturnal hemodialysis
More frequent hemodialysis
Every other day short daily hemodialysis
More frequent hemodialysis
Every other night hemodialysis
More frequent hemodialysis
5 days per week short daily hemodialysis
More frequent hemodialysis
5 nights per week hemodialysis
Conventional Hemodialysis
3 days per week short daily hemodialysis
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18 years of age.
* History of compliance with a dialysis treatment schedule, or if a new patient, express a willingness to be compliant with a treatment schedule.
* Plan to continue care and follow-up at the investigational site.
* Able to sign the informed consent and other relevant documents.
Exclusion Criteria
* Pregnancy.
* Intravenous drug abuser.
* Expects to receive a transplant or transfer to another facility within six months of entering the study.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Satellite Healthcare
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
John Moran, MD
Role: STUDY_DIRECTOR
Satellite Healthcare, Inc.
Brigittte Schiller-Moran, MD
Role: PRINCIPAL_INVESTIGATOR
Satellite Healthcare, Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Satellite Healthcare, Inc.
Mountain View, California, United States
WellBound, Inc.
Mountain View, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SR002MFD
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.